Skip to main content

Senator Tina Smith’s Bill Holds Drug Companies Accountable for Their Predatory Practices and Provides Desperately-Needed Relief to Americans with Diabetes

By July 12, 2019No Comments

Washington, DC — Yesterday, U.S. Senator Tina Smith (D-MN) introduced the Emergency Access to Insulin Act of 2019, a bill that would speed up the availability of insulin and drive down costs for the 7.5 million Americans with diabetes who rely on the medication to survive. Protect Our Care chair Leslie Dach issued the following in response:

“Senator Smith’s legislation takes much-needed action to hold drug manufacturers accountable for predatory price gouging while promoting market competition to drive down the price of insulin. While drug companies continue to raise prices on life-saving drugs just to line their pockets, Senator Smith and her Democratic colleagues continue to fight for the lower costs and better care that every American deserves.”